Talbot, A., Li, K., Lee, J. H. J., Lang, S., Mortazavi, Y., Almudhfar, N., Muldoon, J., Kalter, N., Krishnappa, N., Sachdeva, S., Shukla, S., Sadik, M., Kong, D., Houser, D., Paruthiyil, S., Ahmadi, M., Ji, Y., Acevedo, L., Liang, B., Leon, E. D., Dantuluri, J., Giannikopoulos, P., Hendel, A., Oh, D., Martin, T., Marson, A., Eyquem, J., Shy, B. (2025). Preclinical development of an optimized manufacturing, CRISPR-edited, fully non-viral 1XX-enhanced anti-BCMA CAR-T therapy for multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-5958